X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE AUROBINDO PHARMA SUVEN LIFE/
AUROBINDO PHARMA
 
P/E (TTM) x 20.2 15.7 128.9% View Chart
P/BV x 3.8 4.0 93.1% View Chart
Dividend Yield % 1.0 0.4 257.8%  

Financials

 SUVEN LIFE   AUROBINDO PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
AUROBINDO PHARMA
Mar-17
SUVEN LIFE/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs339895 37.8%   
Low Rs144622 23.2%   
Sales per share (Unadj.) Rs39.2254.6 15.4%  
Earnings per share (Unadj.) Rs7.539.3 19.0%  
Cash flow per share (Unadj.) Rs8.846.6 18.8%  
Dividends per share (Unadj.) Rs2.002.50 80.0%  
Dividend yield (eoy) %0.80.3 251.3%  
Book value per share (Unadj.) Rs49.0160.0 30.6%  
Shares outstanding (eoy) m127.28585.88 21.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x6.23.0 206.5%   
Avg P/E ratio x32.419.3 167.6%  
P/CF ratio (eoy) x27.516.3 169.0%  
Price / Book Value ratio x4.94.7 103.9%  
Dividend payout %26.86.4 421.1%   
Avg Mkt Cap Rs m30,732444,390 6.9%   
No. of employees `0001.014.0 6.8%   
Total wages/salary Rs m41617,678 2.4%   
Avg. sales/employee Rs Th5,236.110,667.8 49.1%   
Avg. wages/employee Rs Th436.51,264.3 34.5%   
Avg. net profit/employee Rs Th995.51,645.8 60.5%   
INCOME DATA
Net Sales Rs m4,995149,157 3.3%  
Other income Rs m1941,159 16.7%   
Total revenues Rs m5,189150,316 3.5%   
Gross profit Rs m1,23334,343 3.6%  
Depreciation Rs m1674,276 3.9%   
Interest Rs m54667 8.1%   
Profit before tax Rs m1,20530,558 3.9%   
Minority Interest Rs m050 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2557,597 3.4%   
Profit after tax Rs m95023,012 4.1%  
Gross profit margin %24.723.0 107.2%  
Effective tax rate %21.224.9 85.1%   
Net profit margin %19.015.4 123.2%  
BALANCE SHEET DATA
Current assets Rs m4,98692,062 5.4%   
Current liabilities Rs m1,04266,223 1.6%   
Net working cap to sales %79.017.3 455.8%  
Current ratio x4.81.4 344.1%  
Inventory Days Days61106 57.5%  
Debtors Days Days3968 57.8%  
Net fixed assets Rs m3,12662,919 5.0%   
Share capital Rs m127586 21.7%   
"Free" reserves Rs m3,71793,133 4.0%   
Net worth Rs m6,23693,719 6.7%   
Long term debt Rs m4321,814 23.8%   
Total assets Rs m8,079162,494 5.0%  
Interest coverage x23.246.8 49.6%   
Debt to equity ratio x0.10 358.1%  
Sales to assets ratio x0.60.9 67.4%   
Return on assets %12.414.6 85.3%  
Return on equity %15.224.6 62.0%  
Return on capital %18.932.7 57.7%  
Exports to sales %87.50-   
Imports to sales %12.20-   
Exports (fob) Rs m4,371NA-   
Imports (cif) Rs m611NA-   
Fx inflow Rs m4,66675,838 6.2%   
Fx outflow Rs m94230,224 3.1%   
Net fx Rs m3,72445,613 8.2%   
CASH FLOW
From Operations Rs m92232,786 2.8%  
From Investments Rs m-619-17,870 3.5%  
From Financial Activity Rs m-698-19,153 3.6%  
Net Cashflow Rs m-396-4,239 9.3%  

Share Holding

Indian Promoters % 63.4 54.1 117.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 8.0 -  
FIIs % 0.0 27.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 10.2 357.8%  
Shareholders   37,287 69,601 53.6%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   PIRAMAL ENTERPRISES  GSK PHARMA  DR. DATSONS LABS  DR. REDDYS LAB  NOVARTIS  

Compare SUVEN LIFE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Near Record High; Realty Stocks Bleed(Closing)

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Jan 18, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS